GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xylo Technologies Ltd (NAS:XYLO) » Definitions » EV-to-EBIT

Xylo Technologies (Xylo Technologies) EV-to-EBIT : -0.03 (As of May. 14, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Xylo Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Xylo Technologies's Enterprise Value is $0.64 Mil. Xylo Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-20.27 Mil. Therefore, Xylo Technologies's EV-to-EBIT for today is -0.03.

The historical rank and industry rank for Xylo Technologies's EV-to-EBIT or its related term are showing as below:

XYLO' s EV-to-EBIT Range Over the Past 10 Years
Min: -3.63   Med: 0.12   Max: 1.62
Current: -0.03

During the past 12 years, the highest EV-to-EBIT of Xylo Technologies was 1.62. The lowest was -3.63. And the median was 0.12.

XYLO's EV-to-EBIT is ranked worse than
100% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 20.475 vs XYLO: -0.03

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Xylo Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $12.19 Mil. Xylo Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-20.27 Mil. Xylo Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -166.29%.


Xylo Technologies EV-to-EBIT Historical Data

The historical data trend for Xylo Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xylo Technologies EV-to-EBIT Chart

Xylo Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.12 -1.50 0.08 -1.07 -0.60

Xylo Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 - -1.07 - -0.60

Competitive Comparison of Xylo Technologies's EV-to-EBIT

For the Medical Devices subindustry, Xylo Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xylo Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xylo Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Xylo Technologies's EV-to-EBIT falls into.



Xylo Technologies EV-to-EBIT Calculation

Xylo Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.642/-20.274
=-0.03

Xylo Technologies's current Enterprise Value is $0.64 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Xylo Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-20.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xylo Technologies  (NAS:XYLO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Xylo Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-20.274/12.1920296
=-166.29 %

Xylo Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $12.19 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Xylo Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-20.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xylo Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Xylo Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Xylo Technologies (Xylo Technologies) Business Description

Traded in Other Exchanges
Address
10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.

Xylo Technologies (Xylo Technologies) Headlines